InSysBio announces its participation in 2025 American Conference on Pharmacometrics (ACoP 2025) which is to be held from October 18-21, 2025 at the Gaylord Rockies, Aurora, Colorado, USA. InSysBio team is going to present its QSP modeling services & software to optimize drug development at the Booth #11 and 2 posters in frames of the Conference, namely:

Sunday, October 19, 7:00 AM - 5:00 PM MDT

• S-074 "From Data to Parameters: FIVEDB as a Tool for Efficient QSP Model Calibration" by Ekaterina Goryacheva, Anna Kopeykina, Almina Polinova, Violetta Polinova, Nail Gizzatkulov, Oleg Demin

Monday, October 20, 7:00 AM - 5:00 PM MDT

• M-068 "Optimizing QSP Modeling Workflows with CYTOCON DB: A Comprehensive Repository of In Vivo Cell and Cytokine Concentrations" by Vladislav Leonov, Ekaterina Mogilevskaya, Elita Gerasimuk, Nikolay Pervushin, Nail Gizzatkulov, Oleg Demin

Check out our posters and Booth #11 at ACoP 2025!

About InSysBio

InSysBio is a group of Quantitative Systems Pharmacology (QSP) companies located in Limassol, Cyprus (INSYSBIO CY Ltd) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s cutting-edge QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry and innovative biotech companies. For more information about InSysBio, its solutions and services, visit www.insysbio.com

Share